MAY 22·Insider Monkey▲
Precigen (PGEN): The Best Penny Stock to Buy for Long Term
Precigen (NASDAQ:PGEN) is highlighted as a top long-term penny stock, following positive Q1 earnings and increased price targets from H.C. Wainwright and Citizens. The company reported strong PAPZIMEOS sales exceeding guidance, and is expanding its commercialization efforts while continuing development of PRGN-2009 for HPV-associated cancers. Management expects current cash and PAPZIMEOS sales to fund operations to cash flow break-even by the end of 2026.
MAY 1·Stock Titan→
[DEF 14A] PRECIGEN, INC. Definitive Proxy Statement
Precigen, Inc. (PGEN) is holding its 2026 Annual Meeting on June 18, 2026, where shareholders will vote on key proposals including the election of nine directors, the ratification of Deloitte & Touche LLP as its independent auditor, an advisory vote on 2025 executive compensation, and an amendment to increase the shares available under the 2023 Omnibus Incentive Plan by 7 million. The company's 2025 performance highlights include FDA approval and initial launch of Papzimeos, and the proxy statement details corporate governance, director and executive pay, and beneficial ownership.
